OncoLink Cancer Treatment and Resources

Treatment Options for Canine Transitional Cell Carcinoma of the Bladder

Lili Duda, VMD
Last Modified: November 1, 2001

Question
Dear OncoLink "Ask the Experts,"
Our 5 and a half-year-old male Cocker Spaniel was recently diagnosed with transitional cell carcinoma of the bladder. The tumor is located in an area where surgical removal is a possibility, but not recommended. My wife and I have opted to begin treatment for him by administering Cytosec daily, along with another medication to help deter any GI distress. What are the usual side effects with the use of this medication? We feel so helpless now and we want to everything within our means to help our boy.  
Thank you!


Answer
Lili Duda, VMD, Editor of the OncoLink Veterinary Oncology Section, responds:

Transitional cell carcinoma is the most common type of bladder cancer in dogs. While these tumors can appear as solitary discrete masses on diagnostic tests such as X-rays and sonograms, there is often undetectable microscopic extension well beyond the apparent tumor mass. This is why surgery is not strongly encouraged for these tumors. Conventional chemotherapy regimens have a very modest palliative effect on these tumors. Recently, a nonsteroidal anti-inflammatory drug (NSAID) called piroxicam (trade name Feldene) has been shown to have some anti-tumor activity against several canine cancers, including transitional cell carcinoma. Therefore, piroxicam has two potentially beneficial effects. First, it is very effective when combined with the appropriate antibiotics in decreasing inflammation associated with infections. This alone can greatly improve symptoms, and is often effective within 1-2 days. In addition, it is helpful in relieving pain associated with tumor-induced inflammation.

As a separate mechanism, piroxicam can also have anti-tumor activity. This anti-tumor effect may take weeks to months to become manifest. So, as long as the dog is tolerating the piroxicam well, and the symptoms associated with the tumor seem to be improved, then it is worth maintaining the dog on piroxicam even if the tumor does not decrease in size right away.

Piroxicam, similar to other NSAIDs such as aspirin and ibuprofen, can cause gastrointestinal irritation and ulceration. Therefore, anti-ulcer medications such as misoprostol (trade name Cytotec) are often prescribed prophylactically to try and avoid NSAID side effects. NSAIDs should be given with a meal, and dogs receiving these drugs should be monitored closely for signs of GI upset, such as loss of appetite, depression, vomiting (especially if of a coffee grounds appearance), and black tar-like stools. If any of these symptoms occur, stop the NSAID, continue with any prescribed anti-ulcer medications, and call your veterinarian immediately.


OncoLink I wish u knew...

As an oncologist, Dr. Giantonio provides care for many patients at the end of life, which he describes as a privilege and rewarding. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS